SARG: A new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens

9Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A new cell line (SARG) was established from a human radiation-induced osteosarcoma (OSA). It showed an epithelial-like morphology with polimorphous and sometimes bizarre nuclei. SARG had an osteoblastic differentiation pattern: almost 100% of the cells were positive for alkaline phosphatase, type I and III collagens and osteonectin. The expression of class I HLA antigens was detectable even after 40 in vitro passages. The expression of MHC antigens was greatly increased after in vitro treatment with interferon gamma (IFN-γ), whereas interferon alpha (IFN-α) and tumor necrosis factor alpha (TNF-α) increased the expression of class I antigens, but not of class II antigens. SARG was tumorigenic after subcutaneous injection in nude mice. Experimental metastases were never detected.

Cite

CITATION STYLE

APA

Scotlandi, K., Serra, M., Landuzzi, L., & Baldini, B. (1992). SARG: A new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens. In Annals of Oncology (Vol. 3, pp. 29–31). https://doi.org/10.1093/annonc/3.suppl_2.s29

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free